Results 191 to 200 of about 48,541 (237)
Emerging Radiopharmaceuticals Beyond FDG for Ovarian Cancer: A Review of Advances in Nuclear Medicine. [PDF]
Cancer MedVeenstra MMK +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals
Nuclear Medicine Communications, 2021Radiopharmaceuticals are radioactive compounds used in nuclear medicine, consisting of a radioactive moiety and a pharmaceutical part. Radiopharmaceuticals are used for diagnosis (predominantly) and therapy (to a lesser extent). Adverse drug reactions are undesirable, unexpected, often harmful drug responses that occur when the drug is administered in ...
Humeyra, Battal, Asuman Yekta, Ozer
openaire +2 more sources
Therapeutic Radiopharmaceuticals
Chemical Reviews, 1999W A, Volkert, T J, Hoffman
exaly +3 more sources
International Journal of Radiation Oncology*Biology*Physics, 2006
The term "naked" radiopharmaceuticals, more appropriately, "unbound" radiopharmaceuticals, refers to any radioisotope used for clinical research or clinical purposes that is not attached to a chemical or biological carrier, and that localizes in various tissues because of a physiologic or chemical propensity/affinity, or secondary to focal anatomic ...
openaire +2 more sources
The term "naked" radiopharmaceuticals, more appropriately, "unbound" radiopharmaceuticals, refers to any radioisotope used for clinical research or clinical purposes that is not attached to a chemical or biological carrier, and that localizes in various tissues because of a physiologic or chemical propensity/affinity, or secondary to focal anatomic ...
openaire +2 more sources
Radiolabeled carbon-based nanostructures: New radiopharmaceuticals for cancer therapy?
Coordination Chemistry Reviews, 2021Mehdi Jaymand +2 more
exaly